Talk to Sam
+1 718 473 0872
Search inside this page
Free Market Research Guides to Download
... Was due to the consolidation of fasa. It is worth noting that our retail pharmacy division operates with a gross margin level that is higher than our distribution division, due to the nature of its business ...
... In our retail pharmacy division, on january 19, 2012 we concluded the negotiations to sell our peruvian operations (boticas fasa) to quitafex, s.A. As a result, we will no longer operate in peru ...
» Purchase Premium Reports (From $ 125 - $ 563)3 reports
Synopsis ICD Research's "Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...
Reportlinker.com © Copyright 2014. All rights reserved.